Disseminated phaeohyphomycosis is a rare and typically fatal infection caused by members of the dematiaceous fungi, and occurs almost universally in the setting of immunocompromise. We herein report a case of systemic phaeohyphomycosis caused by Ochroconis gallopavum in a patient with advanced HIV disease. A possible risk factor for this infection in our patient was heavy marijuana use. This case highlights both the diagnostic and management challenges posed by these infections. To our knowledge, this is the first reported case of disseminated phaeohyphomycosis due to Ochroconis gallopavum in a patient with HIV.
Introduction
Phaeohyphomycosis constitutes an invasive tissue infection caused by dematiaceous, or black, moulds. While dematiaceous fungi are ubiquitously distributed throughout the environment, they infrequently cause disease in humans, and almost universally in the setting of compromised host immunity. Ochroconis gallopavum is a rare cause of phaeohyphomycosis in humans, with only 15 documented cases to date. Of the previously reported cases, 14 occurred in individuals with evidence of immunosuppression, though to our knowledge, this case report is the first to describe systemic O. gallopavum infection in an HIV-infected person. We herein provide a brief topical overview of human O. gallopavum infections, and describe the diagnostic and therapeutic challenges commonly encountered in the management of systemic phaeohyphomycosis.
Case report
A 28-year-old native Canadian man presented to the emergency room with a 4-week history of worsening cough productive of green sputum, exertional dyspnea, fever, sweats, non-bloody diarrhea, persistent left groin pain, and a 40-lb weight loss. He also complained of a 2 day history of left anterior pleuritic chest pain.
Past medical history was notable for HIV infection diagnosed 4 years earlier. He had had irregular followup and had received no prophylaxis or anti-retroviral therapy. His last known CD4 count from 7 months prior to presentation was 294/ml. His HIV viral load was unknown. He had a history of heavy alcohol and marijuana use, took no regular medications, had no drug allergies, and smoked cigarettes occasionally.
Physical examination was notable for fever (temperature 38.68C), tachycardia (HR 103), and exertional hypoxia (oxygen saturation 88% on room air). Blood pressure was 115/70 mmHg with no pulsus paradoxus. Chest examination was remarkable for coarse rales in the right middle lobe (RML) distribution and diffuse wheezes. Examination of the head and neck, precordium, abdomen, and skin revealed no abnormalities. Neurologically, the patient was intact. Musculoskeletal exam revealed decreased range-of-motion of the left hip, and diminished weight-bearing capacity.
Initial blood laboratory investigations revealed a total leukocyte count of 21)/10 9 /l with a neutrophil count of 20)/10 9 /l. Hemoglobin was 120 g/l and platelets were 632)/10 9 /l. Serum electrolytes were normal, but the patient's serum creatinine level was elevated at 131 mmol/l. Liver profile revealed an elevated alkaline phosphatase of 369 U/l, but was otherwise normal. The serum lactate dehydrogenase level was 216 U/l, and his cardiac enzymes were within normal range. His electrocardiogram revealed diffuse ST elevation with PR elevation in AVR (Fig. 1A) . Chest radiograph was notable for patchy bilateral opacities, most prominent in the RML distribution (Fig. 1B) .
The patient was admitted with a diagnosis of community-acquired pneumonia, pericarditis, as well as left hip pain and diarrhea of unclear origin. He was started on ceftriaxone and azithromycin for typical causes of community-acquired pneumonia and treatment doses of trimethoprim-sulfamethoxazole for possible Pneumocystis jirovecki pneumonia (PCP) along with fluconazole prophylaxis. He was given indomethacin for his pericarditis. Blood and urine cultures were taken, and sputum was sent for acid-fast bacilli (AFB), PCP, and culture and sensitivity (C&S), all of which were negative. A transthoracic echocardiogram revealed a left ventricular ejection fraction of /60% with no evidence of pericardial effusion. Stool studies for Clostridium difficile, ova and parasites, and C&S were negative.
The patient remained febrile and achieved only minimal subjective improvement with the above interventions. CD4 count from admission was 79/ml. Repeat chest radiograph on day 6 of admission showed worsening bilateral airspace disease (Fig. 1C) . A computed tomography (CT) of the chest confirmed panlobar consolidation with significant parenchymal destruction (Fig. 1D) . A CT abdomen revealed a complex collection in the left obturator internus which tracked into the left hip joint causing an effusion (Fig.  1E) . Because of the deterioriation in the patient's respiratory status, he was switched from ceftriaxone to piperacillin-tazobactam, and bronchoscopy was arranged. At bronchoscopy on day 8 of admission, frank pus was noted in the airways, and bronchoalveolar lavage (BAL) washings were sent for AFB, C&S, and KOH preparation with fungal culture. On day 8 of admission, the sputum culture from day 6 was positive for heavy growth of Aspergillus species. In addition, the KOH of BAL fluid revealed hyaline, septate hyphae, and the transbronchial biopsy specimen also noted fungi with hyphae and granulomatous inflammation (Fig. 1F,1G ). Ultrasound-guided drainage of the hip abscess yielded purulent material, which also revealed hyaline, septate hyphae on KOH preparation.
The patient was started on oral voriconazole 200 mg BID for invasive pulmonary aspergillosis and antibiotics were discontinued. The patient defervesced and achieved moderate clinical improvement with voriconazole. However, on day 13 of admission, his fever recurred. At the same time, culture of the BAL fluid became positive for Aspergillus fumigatus (light growth) and heavy growth of a second unidentified filamentous fungus, the latter of which was also, and exclusively, grown from the hip aspirate drawn 5 days earlier on day 8. Macroscopically, colonies of this unidentified fungus appeared dark brown on each of brain-heart infusion agar, inhibitory mould agar, and Sabouraud's agar. Microscopically, lactophenol cotton blue preparation revealed septate hyphae with ovoid bodies. This organism was sent to the Laboratories Branch of the Ontario Ministry of Health and Longterm Care for further identification. The patient's dose of voriconazole was increased to 300 mg po BID, and caspofungin 50 mg iv q24 h was added.
Over the subsequent 2 days, his level of consciousness deteriorated. On day 17 of admission, he was intubated for respiratory distress, and an emergent CT head was performed, which revealed a large cerebellar hemorrhage, hydrocephalus, and intraventricular hemorrhage (Fig. 1H) . The patient underwent urgent craniotomy, but unfortunately, suffered a respiratory arrest in the immediate post-operative period and did not survive. Post-mortem examination was not conducted.
Twenty-six days after admission, and 9 days after death, speciation of the filamentous fungus isolated from the BAL and hip aspirate was confirmed as Ochroconis gallopavum by the Laboratories Branch of the Ontario Ministry of Health and Long-term Care. At this reference laboratory, the darkly pigmented mould was sub-cultured onto cycloheximide, pyruvate, and benomyl containing media, and incubated at 308C. The specimen was further sub-cultured onto Leonian's agar, and incubated at 30, 37, 40, 45, and 528C. Inoculated media were examined weekly for growth. At 1 week, moderate growth of a dry, flat, brown-black fungus with diffusible brown pigment was noted on pyruvate and Leonian's agar up to 458C. No growth was observed on cycloheximide or benomyl agar, nor was there growth on Leonian's agar at 528C. Microscopically, branched, hyaline septate hyphae were noted, with clavate, 2-celled, smooth, thin-walled conidia with septal constriction and frilled denticles. Differentiation from other species of Ochroconis was based on the presence of clavate, asymmetric, septate conidia, lack of growth on cycloheximide and benomyl agar, and growth tolerance of temperatures up to 458C.
Discussion
Phaeohyphomycosis refers to a local or systemic tissue infection caused by members of the dematiaceous, or black, fungi. Ochroconis gallopavum (previously named Dactylaria gallopava) is one such species, and is a rare cause of phaeohyphomycosis in humans. The case reported herein highlights both the diagnostic and management challenges posed by these infections.
Dematiaceous fungi are widely distributed in the environment, isolated often from soil and wood, and are found worldwide [1] . They are a rare cause of disease in humans, with one population-based surveillance study in San Francisco reporting an incidence of black mould infection of 1 case per million per year [2] . However, the number of reported cases has increased over the past decade [3] . Altered host immunity in the form of depressed cell-mediated immune function is perhaps the largest contributor to the rising incidence [3, 4] , with phaeohyphomycosis caused by Ochroconis spp. occurring almost exclusively in the immunocompromised [5] . Documented risk factors for phaeohyphomycosis include hematologic malignancy, bonemarrow or solid-organ transplantation, AIDS, agranulocytosis, diabetes mellitus, steroid use, and chronic granulomatous disease [1, 3, 5, 6] . Of the 15 reported cases of human O. gallopavum infection to date, eight occurred in transplant recipients [5,7 Á13 ], 5 in those with hematologic malignancies [14 Á18 ], one in a patient with pemphigus [19] , and one in a healthy individual with a significant environmental exposure history [20] (Table 1) . Dematiaceous moulds other than O. gallopavum have been reported in patients with underlying HIV infection and include Hormonema dematioides [21] , Scytalidium dimidiatum [22] , and Scedosporium prolificans [23] .
In our patient, another possible risk factor for disseminated phaeohyphomycosis was heavy marijuana use. Marijuana leaves are known to be contaminated with fungal spores [24] , and marijuana smoking has been documented to be a risk factor for invasive aspergillosis in a variety of immunocompromised hosts [25 Á27] . Specific counseling of patients with depressed cell-mediated immunity or neutropenia who use streetgrade marijuana for recreational or medicinal purposes may therefore be indicated. From a single random sample of street-grade marijuana in Toronto, we were able to culture several species of potentially pathogenic fungi including Scopulariopsis spp., Penicillium spp., Cladosporium spp., and Ulocladium spp. (unpubl.data). While we were unable to isolate O. gallopavum from this single sample, it is reasonable to believe that this species may also contaminate street-grade marijuana. Substantiation of this hypothesis through a larger prevalence series would be of interest.
Phaeohyphomycosis has been attributed to over 100 species and 60 genera of dematiaceous fungi [3] . There are 4 clinical classifications of phaeohyphomycosis: superficial, cutaneous, subcutaneous, and systemic, the latter of which occurred in our patient. Inhalation of conidia with subsequent dissemination is thought to be the pathogenesis of systemic disease1. Dematiaceous fungi are particularly neurotropic, and CNS phaeohyphomycosis is a common systemic form [3] . Involvement of the lungs, endocardium, bones, joints, eyes, and gastrointestinal tract have all been reported. Amongst cases of disseminated disease, documented fungemia occurs frequently [3] . Our patient likely had involvement of the lungs, pericardium, joints, and CNS. Involvement of his gastrointestinal tract was also a possibility, given his diarrhea.
The diagnosis of phaeohyphomycosis is challenging due to the rarity of disease and ubiquity of causative organisms, which are often considered laboratory contaminants. Disease, when it occurs, tends to be non-specific with an insidious onset. Currently, there are no commercially available molecular techniques that can rapidly and reliably diagnose these infections [6] , thus, culture and microscopic exam remain the gold standard for diagnosis. Macroscopically, dematiaceous fungi form dark grey to black, heaped, velvety colonies on Sabouraud agar [1] . O. gallopavum is tolerant of temperatures up to 458C, and fails to grow on benomyl or cycloheximide agar. Microscopically, they have an irregular, toruloid hyphal structure, with yeast-like forms as well [1] . Microscopically, O. gallopavum has characteristic two-celled, clavate, nearly hyaline conidia, and thick-walled brown hyphae. In tissue, the Masson-Fontana melanin-specific stain permits the detection of the brown hyphal walls typical of dematiaceous fungi. As illustrated by our case, morphology can be non-specific, and dematiaceous fungi can resemble hyaline, septate moulds, such as Aspergillus, using routine histopathology fungal stains, leading to inappropriate empiric therapy. This emphasizes the importance of Masson-Fontana staining to distinguish between hyaline and dematiaceous fungi, which was not performed in this case. In addition, faster growing species such as Aspergillus can dominate a culture and obscure the true pathogen. In the case described, Aspergillus was a likely colonizer of the respiratory tree, and was probably non-invasive, although invasive aspergillosis cannot be ruled out completely. Management of phaeohyphomycosis is challenging due to a lack of evidence around treatment strategies and the high mortality rate, which in two large series, approached 80% [3, 6] . To date, there are no published trials of pharmacotherapy for phaeohyphomycosis. Amphotericin B, which is the historical first-line therapeutic agent, has shown limited success in systemic phaeohyphomycosis, but remains the drug-ofchoice for life-threatening disease [1, 3, 4] . Itraconazole has shown the most consistent and potent in vitro activity against dematiaceous fungi [28] , has been used successfully in cutaneous and subcutaneous infection, and is the first line agent for treatment of non-lifethreatening disease [1, 3, 4] . Newer tertiary azoles, such as voriconazole, are potent with broad-spectrum in vitro activity against dematiaceous fungi [29] , though clinical experience is extremely limited. Among the cases of human Ochroconis infection, only two were treated with voriconazole, and both had fatal outcomes (Table 1) . However, these drugs achieve excellent CSF and tissue concentrations [30] , and therefore hold promise in the management of phaeohyphomycosis. Echinocandins, such as caspofungin, demonstrate much lower in vitro activity than either itraconazole or tertiary azoles [31] , and again clinical experience is limited in the setting of phaeohyphomycosis [1, 3, 6] . Their role in the treatment of these types of infections remains unclear [3, 31] . While terbinafine demonstrates significant in vitro activity against dematiaceous fungi [32] , its clinical successes have been limited to cases of cutaneous rather than systemic phaeohyphomycosis [33, 34] . There is no single agent which shows clinical superiority in the management of systemic phaeohyphomycosis, and combination therapy confers no mortality benefit [3, 6] .
In summary, systemic phaeohyphomycosis is a rare but deadly disease in humans caused by dematiaceous fungi. The case of human O. gallopavum infection in an HIV-positive person reported herein, highlights the diagnostic and management challenges presented by phaeohyphomycosis, and underscores its grave prognosis. Isolation of a black mould from a patient specimen should be considered seriously, particularly in the setting of known defects in cell-mediated immune function. Current treatment options are limited, and there is a dire need for empiric evidence surrounding therapeutic strategies.
